000024863 000__ 01480cam\a2200445\i\4500
000024863 001__ 24863
000024863 003__ SzGeWIPO
000024863 005__ 20240708162110.0
000024863 008__ 071126s2008    enk|||||r|||| 00| 0 eng d
000024863 035__ $$a(wipo)0
000024863 035__ $$a(OCoLC)1161655955
000024863 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000024863 041__ $$aeng
000024863 043__ $$ae------
000024863 050_4 $$aK1501.2$$b.P38
000024863 08204 $$a346.0486$$220
000024863 084__ $$a53$$qGB
000024863 1001_ $$aHill, J.,$$eauthor.
000024863 24510 $$aEmery weigh up the pros and cons of the London Agreement on EU patents /$$cHill, J., Holmes, S.
000024863 264_1 $$aLondon [England] :$$bInforma Law,$$c2008.
000024863 300__ $$a1 volume ([2] pages) ;$$c[28] cm.
000024863 336__ $$atext$$btxt$$2rdacontent
000024863 337__ $$aunmediated$$bn$$2rdamedia
000024863 338__ $$avolume$$bnc$$2rdacarrier
000024863 4901_ $$aPatent World,$$x0950-2513 ;$$vGB 53 Jun 2008 No 206, pages 28-30
000024863 500__ $$aIs compulsory licensing the answer to ensure access to medicines in the developing world? Patrick Kierans and Josée Gravelle of Ogilvy Renault say the effectiveness of Canada's regime is under question [Source:Patent World].
000024863 650_0 $$aPatent laws and legislation.
000024863 650_0 $$aComputer software$$vPatents.
000024863 650_0 $$aTrademarks$$xLaw and legislation.
000024863 650_0 $$aBiotechnology industries$$vPatents.
000024863 650_0 $$aIntellectual property.
000024863 650_0 $$aPatents$$zEurope.
000024863 650_4 $$aPatents$$zEuropean Union$$xLondon Agreement on EU patents
000024863 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000024863 7001_ $$aHolmes, S.
000024863 830_0 $$aPatent World ;$$vGB 53 Jun 2008 No 206, pages 28-30.
000024863 903__ $$aPatent World.
000024863 904__ $$aJournal article
000024863 942__ $$cART$$jGB 53 Jun 2008 No 206$$2ddc
000024863 952__ $$w2009-02-02$$p2009-0096$$u38637$$bMAIN$$10$$kGB 53$$v2009-02-02$$70$$cMain Library$$yART
000024863 980__ $$aBIB
000024863 999__ $$c27170$$d27170